Xenetic Biosciences Announces Deal To Acquire Santersus AG In All-Stock Share Exchange; Xenetic Holders To Own About 15%, Santersus Holders About 85%; To Trade As Santersus Bio Under Ticker SNTS
Share
Why It Matters
Xenetic is merging with Santersus AG. After the deal closes, Xenetic shareholders will own a small part of the combined company.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.